FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Illumina | Genomics

Illumina: Cheap DNA mapping will become routine

Illumina CEO Jay Flatley says that in five years we'll have the kind of affordable technology needed to map every child's DNA at birth. And in 10 years, Flatley predicted in an interview with The Times, the service will become a routine offering.

Armed with that information, a doctor would be able to get an accurate idea of a person's risk for disease, allowing them to suggest preventive methods to avoid disease as well as early screening to detect high-risk conditions at an early stage.

Illumina, which plans to offer whole-genome sequencing within two years for as little as $10,000, adds that soon the only barriers to DNA mapping will be fear that insurers or employers could get a copy of your DNA and use the information against you. That in turn will prompt governments to pass new laws, much like the U.S. has already done, to guard against the misuse of a person's genetic profile.

"The limitations are sociological; when and where people think it can be applied, the concerns people have about misinformation and the background ethics questions," says Flatley. In just four years, says Flatley, DNA mapping will cost less than $1,000.

- read the story in The Times

Related Articles:
Illumina deal highlights hunt for sub-$1,000 sequencing
Illumina snares sequencing tech in $60M buyout
Illumina focuses on molecular diagnostics
Four companies lead genome sequencing race


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Research Email Newsletter:
Be the first to comment
More stories about Illumina   Genomics  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.